MELIOR PHARMACEUTICALS
Many blockbuster drugs were only serendipitously discovered to be efficacious in the indications for which they were ultimately marketed. For example, Viagra® ($2 billion annual sales), Gemzar® ($1.2 billion annual sales), Evista® ($1.0 billion annual sales) and Propecia® are all examples of drugs that were originally developed for use in one indication but, by chance, were discovered to be effective for a very different one.
MELIOR PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2010-01-01
Address:
Exton, Pennsylvania, United States
Country:
United States
Website Url:
http://www.meliorpharmaceuticals.com
Total Employee:
1+
Status:
Active
Contact:
(610) 280-0633
Email Addresses:
[email protected]
Total Funding:
375 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Tag Manager Google Universal Analytics Global Site Tag Typekit EmailMeForm
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.meliorpharmaceuticals.com Semrush global rank: 5.85 M Semrush visits lastest month: 1.42 K
- Host name: vux.netsolhost.com
- IP address: 206.188.193.17
- Location: Jacksonville United States
- Latitude: 30.1426
- Longitude: -81.5727
- Metro Code: 561
- Timezone: America/New_York
- Postal: 32258
More informations about "Melior Pharmaceuticals"
Melior Pharmaceuticals | Biopharmaceutical Research
Expanding the Pipeline. Melior’s pipeline includes, (1) Tolimidone, a novel lyn kinase activator, currently in development for Type 2 Diabetes and NASH, and (2) Mesocarb, a highly selective …See details»
Management Team - Melior Pharmaceuticals
Dr. Reaume founded Melior Discovery Inc fourteen years ago and built it into a robust self-sustaining drug discovery organization. He subsequently spun off two sister companies with …See details»
Melior Pharmaceuticals - Crunchbase Company Profile & Funding
Many blockbuster drugs were only serendipitously discovered to be efficacious in the indications for which they were ultimately marketed. For example, Viagra® ($2 billion annual sales), …See details»
About Us - Melior Pharmaceuticals
About Us. Melior Pharmaceuticals is a mid-stage biopharmaceutical company developing a pipeline of de-risked therapies in areas with significant unmet needs.See details»
Melior Announces Substantial Additions to Its ... - Business Wire
Apr 12, 2022 Joining the Melior organization will be Dr. Ken Melior Announces Substantial Additions to Its Management and Scientific Team Dr. Ken Kilgore joins Melior as VP of …See details»
Melior Pharmaceuticals I, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Melior Pharmaceuticals I, Inc. of Exton, PA. Get the latest business insights from Dun & Bradstreet.See details»
Overview, News & Similar companies - ZoomInfo.com
View Melior Pharmaceuticals (www.meliorpharmaceuticals.com) location in Pennsylvania, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Melior Pharmaceuticals - Products, Competitors, Financials, …
Meliorpharmaceuticals.com. Overview & Products; About Melior Pharmaceuticals. Melior Pharmaceuticals is a mid-stage biopharmaceutical company focused on developing innovative …See details»
Melior Pharmaceuticals (USA) Funding: $375K - Medical Startups
Mar 11, 2025 Melior Pharmaceuticals is a clinical stage pharmaceutical company developing treatment for metabolic disease and skin...See details»
Melior Pharmaceuticals - VentureRadar
Melior Pharmaceuticals is a mid-stage biopharmaceutical company developing a pipeline of drug candidates for Type 2 Diabetes, Nonalcoholic... ... Find out more about ...See details»
Melior Pharmaceuticals - Company Profile - Tracxn
Feb 24, 2025 Melior is dedicated to uncovering new therapeutic applications for partners' existing drugs. By utilizing the unique and highly efficient theraTRACE indications discovery …See details»
Melior Pharmaceuticals I, Inc. (Melior Pharmaceuticals I, Inc.) - 药物 …
Meliorpharmaceuticals.com. ... The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 2016; 131:803–820 (5) Jansen et …See details»
Melior Pharmaceuticals - Biotech Careers
Melior Pharmaceuticals is a mid-stage biopharmaceutical company developing a pipeline of drug candidates for Type 2 Diabetes, Nonalcoholic Steatohepatitis (NASH), Parkinson’s Disease …See details»
Melior Pharmaceuticals, Inc. | Insights
Jun 10, 2021 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
News & Press Releases - Melior Pharmaceuticals
Sep 15, 2020 PRESS RELEASE Melior Pharmaceuticals Receives IND Clearance from US FDA for COVID-19 Therapeutic. March 9, 2021. READ MORE DOWNLOAD PDFSee details»
Melior Pharmaceuticals - VentureRadar
Website: http://meliorpharmaceuticals.com/ Melior Pharmaceuticals is a mid-stage biopharmaceutical company developing a pipeline of drug candidates for Type 2 ...See details»
Melior Pharmaceuticals Culture | Comparably
Learn about Melior Pharmaceuticals' culture, see what work's like, read reviews, and find job opportunities.See details»
Melior Discovery - Wikipedia
The company specializes in drug repositioning and has established a proprietary phenotypic screening platform that it uses for this purpose. Melior also offers certain contract research …See details»
Technology Melior Pharmaceuticals | Melior Affiliate
Melior Discovery. Melior Pharmaceuticals leverages the proprietary technology if its affiliate company, Melior Discovery, to identify new indications for drugs that have existing clinical data …See details»
Simplification for success: Rewiring the biopharma operating model
3 days ago Thirty-seven of them expect their organization to pursue a simplification effort over the next 12 months. Thirty-two respondents say they believe they need a significantly different …See details»